Search
The Institute of Applied Health Sciences

Professor David Price

In this section
Professor David Price
Professor David Price
Professor David Price

Chair of Primary Care Respiratory Med

About
Email Address
d.price@abdn.ac.uk
Telephone Number
+44 (0)1224 437237
School/Department
School of Medicine, Medical Sciences and Nutrition
Publications

Page 23 of 93 Results 221 to 230 of 923

  • Persistent OCS reduction regardless of starting OCS dose in patients with severe, OCS-dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study

    Cosio, B. G., Domingo, C., Gurnell, M., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    15º Congreso ALAT 2022
    Contributions to Conferences: Abstracts

  • Characterisation of the Australian adult population living with asthma: Severe exacerbation frequency, long-term OCS use and adverse effects.

    Hancock, K. L., Bosnic-Anticevich, S. Z., Blakey, J., Hew, M., Chung, L. P., Cvetkovski, B., Claxton, S., Del Fante, P., Denton, E., Doan, J., Ranasinghe, K., Morgan, L., Sharma, A., Smith, P. K., Stewart, D., Thompson, P. J., Wiseman, R., Upham, J. W., Yan, K. Y., Carter, V., Dhillon, K., Heraud, F., Le, T., Vella, R., Price, D.
    Pragmatic and Observational Research, vol. 2022, pp. 43-58
    Contributions to Journals: Articles

  • Healthcare resource utilisation associated with intermittent oral corticosteroid use in asthma

    Heatley, H., Tran, T. N., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Henley, W., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
    EAACI HYBRID CONGRESS 2022
    Contributions to Conferences: Abstracts

  • Biologics in severe asthma: the role of real-world evidence from registries

    Paoletti, G., Pepys, J., Casini, M., Di Bona, D., Heffler, E., Goh, C. Y., Price, D. B., Canonica, G. W.
    European Respiratory Review, vol. 31, no. 164, 210278
    Contributions to Journals: Articles

  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    2022 AANP National Conference
    Contributions to Conferences: Posters

  • Let’s improve COPD prognosis: a practical tool for primary care providers to identify the frequency and follow-up of COPD lung attacks

    Gerritsma, Y., Leving,, M., Dijk, L., van der Ham, I., Metz, B., Price, D., Salomé, P., Ställberg, B., Quint, J., Kocks, J.
    Dutch Lung Congress 2022
    Contributions to Conferences: Abstracts

  • Reply to: Cause or consequence?

    Bateman, E. D., Price, D., Wang, H., Schonffeldt, P., Catanzariti, A., van der Valk, R. J., Beekman, M. J.
    European Respiratory Journal, vol. 59, no. 6, 2200103
    Contributions to Journals: Comments and Debates

  • Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial

    Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongste, J. C., Pijnenburg, M. W., Thomas, M., Price, D.
    The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592
    Contributions to Journals: Articles

  • Reducción persistente de corticosteroides orales independientemente de la dosis basal, en pacientes con asma córtico-dependiente tratados con dupilumab: Estudio Liberty Asthma-Traverse

    Domingo, C., Gurnell, M., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    55 Congreso Separ, pp. 75
    Contributions to Journals: Abstracts

  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    The 35th annual
    Eastern Allergy Conference, pp. S9
    Contributions to Conferences: Abstracts
Show 10 | 25 | 50 | 100 results per page

Refine

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Contributions to Specialist Publications

Working Papers

Other Contributions

Update